T. cruzi does not synthesize sialic acid, but the infective trypomastigotes contain an unusual trans-sialidase (TS) on their surface membranes. Within seconds after leaving host cells to enter the blood stream, the trypomastigote surface glycoproteins are sialylated. This reaction leads to the assembly of the Ssp-3 epitope, which plays a essential role in the adhesion and subsequent invasion of other host cells. The TS does not employ CMP-NeuAc, the normally used donor for sialic acid transfer reactions. Such a TS has not been described in mammalian cells, making the enzyme a potential target for chemotherapy. Independently of the possible role of TS in the biology of T. cruzi and pathology of Chagas' disease, the Ts is of particular interest to carbohydrate biochemists. In this proposal we describe experimental approaches: 1) to clarify the structure and function of the TS, and its relationship to a previously described T. cruzi sialidase. We will: a) clone and express the DNA coding for the TS gene(s) and assay the activity of the product(s) for TS and sialidase activities; b) titrate TS and sialidade in extracts of various strains of T. cruzi, to determine whether the two enzymatic activities are closely correlated, or vary independently of each other; c) isolate the two activities from crude trypomastigote extracts, and verify whether they co-purify; d) study some properties of the isolated enzyme(s). 2) to determine the role of the sialic acid-containing molecules in target cell invasion, and in the protecting trypomastigotes from lysis by complement. 3) to verify whether the sialylated molecules can be ligands for members of the LECCAM family of host receptors, and play a role in the parasite migration in the mammalian host's tissues. 4) to characterize the structure of the oligosaccharides which are sialylated by the TS, and specifically, of L)those oligosaccharides of the Ssp-3-bearing surface molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032966-02
Application #
3148059
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1992-07-01
Project End
1996-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Coppel, R L; Brown, G V; Nussenzweig, V (1998) Adhesive proteins of the malaria parasite. Curr Opin Microbiol 1:472-81
Raper, J; Nussenzweig, V; Tomlinson, S (1996) The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J Exp Med 183:1023-9
Schenkman, S; Eichinger, D; Pereira, M E et al. (1994) Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol 48:499-523
Medina-Acosta, E; Franco, A M; Jansen, A M et al. (1994) Trans-sialidase and sialidase activities discriminate between morphologically indistinguishable trypanosomatids. Eur J Biochem 225:333-9
Tomlinson, S; Pontes de Carvalho, L C; Vandekerckhove, F et al. (1994) Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol 153:3141-7
Pontes de Carvalho, L C; Tomlinson, S; Vandekerckhove, F et al. (1993) Characterization of a novel trans-sialidase of Trypanosoma brucei procyclic trypomastigotes and identification of procyclin as the main sialic acid acceptor. J Exp Med 177:465-74
Tomlinson, S; Pontes de Carvalho, L; Vandekerckhove, F et al. (1992) Resialylation of sialidase-treated sheep and human erythrocytes by Trypanosoma cruzi trans-sialidase: restoration of complement resistance of desialylated sheep erythrocytes. Glycobiology 2:549-51